文献速递糖尿病肥胖与代谢综合征

细胞因子与糖尿病进展的10年社区队列关联

Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-Up From a Community-Based Cohort.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

基于Ansung队列912名40-69岁基线人群,测量8种细胞因子并随访10年。基线糖耐量正常者中,RBP4最高三分位进展为2型糖尿病的风险增加5.48倍;基线糖尿病前期者中,RBP4最高三分位风险增加2.43倍,resistin最高三分位风险增加2.94倍。

要点

  • RBP4最高三分位与糖耐量正常者进展为2型糖尿病风险增加5.48倍相关。
  • PAI-1最高三分位和脂联素最低三分位与糖耐量正常进展为糖尿病前期风险增加相关。
  • 糖尿病前期者中resistin最高三分位与进展为2型糖尿病风险增加2.94倍相关。

核心结论

  • 基线糖耐量正常者中,较高血清RBP4和PAI-1、较低脂联素与新发糖尿病前期和2型糖尿病相关。

研究设计与样本

  • 来自Ansung队列(韩国基因组流行病学研究),纳入912名40-69岁基线参与者。
  • 基线行75g口服葡萄糖耐量试验并检测8种细胞因子,对糖耐量正常(n=241)和糖尿病前期(n=330)者每两年随访10年。
  • 采用多项logistic回归评估细胞因子对新发糖尿病前期和2型糖尿病的预测能力。

主要发现

  • 10年时,糖耐量正常者中38名(15.8%)转为糖尿病前期,82名(34.0%)转为2型糖尿病。
  • 糖尿病前期者中228名(69.1%)转为2型糖尿病。
  • 基线糖耐量正常或糖尿病前期者中,RBP4最高三分位进展为2型糖尿病的风险分别增加5.48倍和2.43倍。
  • 糖耐量正常者中,PAI-1最高三分位和脂联素最低三分位转为糖尿病前期的比值比分别为3.23和3.37。
  • 基线糖尿病前期者中,resistin最高三分位进展为2型糖尿病的风险增加2.94倍(所有P<0.05)。

临床怎么用

  • 对糖耐量正常人群可关注血清RBP4、PAI-1和脂联素水平以评估糖尿病前期和2型糖尿病风险。
  • 对糖尿病前期人群可关注RBP4和resistin水平以评估进展为2型糖尿病的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The long-term association between multiple cytokines and progression to diabetes is still uncertain. OBJECTIVE: To identify which cytokines could predict progression to prediabetes and type 2 diabetes over 10 years. METHODS: The study included 912 participants aged 40 to 69 years at baseline from the Ansung cohort, part of the Korea Genome Epidemiology Study. At baseline, a 75-g oral glucose tolerance test and 8 cytokines were measured: plasminogen activator inhibitor 1 (PAI-1), resistin, interleukin 6, leptin, monocyte chemoattractant protein 1, tumor necrosis factor alpha, retinol binding protein 4 (RBP4), and adiponectin. People with normal glucose tolerance (NGT, n = 241) and prediabetes (n = 330) were followed-up biennially for 10 years. Multinomial logistic regression analysis was used to evaluate the predictability of cytokines on the new-onset prediabetes and type 2 diabetes. RESULTS: At 10 years, 38 (15.8%) and 82 (34.0%) of those with NGT had converted to prediabetes and type 2 diabetes, respectively. Of those with prediabetes, 228 (69.1%) had converted to type 2 diabetes. In people with NGT or prediabetes at baseline, the highest tertile of RBP4 was associated with a 5.48-fold and 2.43-fold higher risk of progression to type 2 diabetes, respectively. The odds for converting from NGT to prediabetes in the highest tertile of PAI-1 and the lowest tertile of adiponectin were 3.23 and 3.37, respectively. In people with prediabetes at baseline, those in the highest tertile of resistin were 2.94 time more likely to develop type 2 diabetes (all P < 0.05). CONCLUSIONS: In this 10-year prospective study, NGT with higher serum RBP4 and PAI-1, and with lower adiponectin were associated with new-onset prediabetes and type 2 diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Cho NH, Ku EJ, Jung KY, et al. Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-Up From a Community-Based Cohort. J Clin Endocrinol Metab. 2020. PMID: 31690939. doi:10.1210/clinem/dgz171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。